Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Primary Urinary Tract Lymphoma: Rare but Aggressive

KONSTANTINOS LONTOS, ANASTASIA TSAGIANNI, PAVLOS MSAOUEL, LEONARD JOSEPH APPLEMAN and DIMITRIOS NASIOUDIS
Anticancer Research December 2017, 37 (12) 6989-6995;
KONSTANTINOS LONTOS
1Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lontosk{at}upmc.edu
ANASTASIA TSAGIANNI
2Division of General Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAVLOS MSAOUEL
3Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LEONARD JOSEPH APPLEMAN
1Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIMITRIOS NASIOUDIS
4Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Cancer-specific survival of patients with primary urinary tract lymphoma stratified by age (N=846, p<0.001). Five-year cancer-specific survival was 65%, 58% and 51% for those aged <60, 60-75 and >75 years, respectively.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Cancer-specific survival of patients with primary urinary tract lymphoma (PLUT) stratified by stage (N=846, p<0.001). Five-year cancer-specific survival was 69%, 58%, 53% and 47% for patients with stage I, II, III and IV disease, respectively.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Cancer-specific survival of patients with primary urinary tract lymphoma stratified by histology (N=846, p≤0.001). Five-year cancer-specific survival was 56%, 78%, 51%, 71% and 88% for patients with Burkitt lymphoma, chronic lymphocytic lymphoma (CLL.), diffuse large B-cell lymphoma (DLBCL), follicular and mucosa-associated lymphoid tissue lymphoma (MALT), respectively.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Cancer-specific survival of patients with stage I-II (N=19173, p<0.001) (A) and stage III-IV diffuse large B-cell lymphoma (N=28,731, p=0.03) (B) stratified by site. Five-year cancer-specific survival for patients with nodal and urinary tract diffuse large B-cell lymphoma was 69% and 59% for those with stage I-II and 46% and 39%, respectively, for those with stage III-IV disease.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 37, Issue 12
December 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Primary Urinary Tract Lymphoma: Rare but Aggressive
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Primary Urinary Tract Lymphoma: Rare but Aggressive
KONSTANTINOS LONTOS, ANASTASIA TSAGIANNI, PAVLOS MSAOUEL, LEONARD JOSEPH APPLEMAN, DIMITRIOS NASIOUDIS
Anticancer Research Dec 2017, 37 (12) 6989-6995;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Primary Urinary Tract Lymphoma: Rare but Aggressive
KONSTANTINOS LONTOS, ANASTASIA TSAGIANNI, PAVLOS MSAOUEL, LEONARD JOSEPH APPLEMAN, DIMITRIOS NASIOUDIS
Anticancer Research Dec 2017, 37 (12) 6989-6995;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy in EGFR-mutant NSCLC After TKI Resistance
  • Prognostic Difference According to the Site of Origin (Major vs. Minor) of Salivary Gland Carcinoma
  • Prognostic Significance of the Lymph Node Ratio in Obstructive Colorectal Cancer: A Retrospective Multicenter Study
Show more Clinical Studies

Keywords

  • Kidney lymphoma
  • renal lymphoma
  • bladder lymphoma
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire